Pharmaceutical Analysis, Drug Discovery and Designing Chemistry

Michael D Winther is Associate Director at the Genome Institute of Singapore (GIS) and Head of offi ce of strategic alliances and knowledge management as of December 2015. Responsible for all agreements with academic, medical and industry organizations, as well as intellectual property developed by GIS. He is also the senior project manager for the national pharmacogenomics project SAPhIRE: Surveillance and Pharmacogenomics of Adverse Drug Reactions (www.saphire.sg). The SAPhIRE programme is developing the knowledge base and tools needed to implement pharmacogenomics at the wider community level to impact safety and effi cacy of biological and small molecule therapeutics. He has over 25 years R&D experience in biologicals and drug discovery with pharmaceutical and biotechnology companies and academia.